The University of Southampton
University of Southampton Institutional Repository

Sex cord stromal testicular tumors: a clinical series - uniformly stage I disease

Sex cord stromal testicular tumors: a clinical series - uniformly stage I disease
Sex cord stromal testicular tumors: a clinical series - uniformly stage I disease
PURPOSE:
Sex cord stromal testicular tumors are rare. Historically 10% of lesions are said to be malignant but to our knowledge there are no clinical or histological features that can accurately predict potential malignant behavior. Because of this, groups at some centers have advocated prophylactic retroperitoneal lymph node dissection in patients with clinical stage I disease. We reviewed our experience with these tumors to determine whether this policy is justified.

MATERIALS AND METHODS:
We retrospectively reviewed the records of all 38 men older than 18 years with sex cord stromal testicular tumors who were referred to the Wessex regional cancer center for treatment or pathological review during the 25-year period of 1982 to 2006. We then compared our series with a malignant sex cord stromal testicular tumor database generated from the world literature.

RESULTS:
All Wessex patients were treated with excision of the primary tumor alone and metastatic disease developed in none. All remained disease-free with an overall median survival of 6.8 years (range 1.4 to 25). Features in the literature favoring malignant behavior, ie metastatic disease, included larger tumors (mean 6.43 vs 1.71 cm), a high mitotic rate, tumor necrosis, angiolymphatic invasion, infiltrative margins and extratesticular extension (each p <0.0001). The malignant group had an overall median survival of 2.3 years (range 0.02 to 17.3).

CONCLUSIONS:
No patient had disease progression in our study, which is to our knowledge the largest reported United Kingdom series of sex cord stromal testicular tumors. Our data suggest that malignancy is uncommon and prophylactic retroperitoneal lymph node dissection is unjustified for clinical stage I disease.
testis, testicular neoplasms, lymph node excision, sex cord-gonadal stromal tumors, neoplasm metastasis
0022-5347
2090-2096
Featherstone, J.M.
abbcbcea-0954-43fc-850b-04aba2dba056
Fernando, H.S.
7bdecd68-0016-48ca-a250-94f202d21cfe
Theaker, J.M.
e24ec934-c79c-471c-8556-d38a15ac845b
Simmonds, P.D.
27d4c068-e352-4cbf-9899-771893788ade
Hayes, M.C.
f9501741-0878-4f10-957b-da14c377c362
Mead, G.M.
8a97f978-9c66-4a16-bb03-dd83d20b06a0
Featherstone, J.M.
abbcbcea-0954-43fc-850b-04aba2dba056
Fernando, H.S.
7bdecd68-0016-48ca-a250-94f202d21cfe
Theaker, J.M.
e24ec934-c79c-471c-8556-d38a15ac845b
Simmonds, P.D.
27d4c068-e352-4cbf-9899-771893788ade
Hayes, M.C.
f9501741-0878-4f10-957b-da14c377c362
Mead, G.M.
8a97f978-9c66-4a16-bb03-dd83d20b06a0

Featherstone, J.M., Fernando, H.S., Theaker, J.M., Simmonds, P.D., Hayes, M.C. and Mead, G.M. (2009) Sex cord stromal testicular tumors: a clinical series - uniformly stage I disease. The Journal of Urology, 181 (5), 2090-2096. (doi:10.1016/j.juro.2009.01.038).

Record type: Article

Abstract

PURPOSE:
Sex cord stromal testicular tumors are rare. Historically 10% of lesions are said to be malignant but to our knowledge there are no clinical or histological features that can accurately predict potential malignant behavior. Because of this, groups at some centers have advocated prophylactic retroperitoneal lymph node dissection in patients with clinical stage I disease. We reviewed our experience with these tumors to determine whether this policy is justified.

MATERIALS AND METHODS:
We retrospectively reviewed the records of all 38 men older than 18 years with sex cord stromal testicular tumors who were referred to the Wessex regional cancer center for treatment or pathological review during the 25-year period of 1982 to 2006. We then compared our series with a malignant sex cord stromal testicular tumor database generated from the world literature.

RESULTS:
All Wessex patients were treated with excision of the primary tumor alone and metastatic disease developed in none. All remained disease-free with an overall median survival of 6.8 years (range 1.4 to 25). Features in the literature favoring malignant behavior, ie metastatic disease, included larger tumors (mean 6.43 vs 1.71 cm), a high mitotic rate, tumor necrosis, angiolymphatic invasion, infiltrative margins and extratesticular extension (each p <0.0001). The malignant group had an overall median survival of 2.3 years (range 0.02 to 17.3).

CONCLUSIONS:
No patient had disease progression in our study, which is to our knowledge the largest reported United Kingdom series of sex cord stromal testicular tumors. Our data suggest that malignancy is uncommon and prophylactic retroperitoneal lymph node dissection is unjustified for clinical stage I disease.

This record has no associated files available for download.

More information

e-pub ahead of print date: 14 March 2009
Published date: May 2009
Keywords: testis, testicular neoplasms, lymph node excision, sex cord-gonadal stromal tumors, neoplasm metastasis
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 73403
URI: http://eprints.soton.ac.uk/id/eprint/73403
ISSN: 0022-5347
PURE UUID: f24845ca-094b-4dab-997d-b34c7f558742

Catalogue record

Date deposited: 16 Mar 2010
Last modified: 13 Mar 2024 22:02

Export record

Altmetrics

Contributors

Author: J.M. Featherstone
Author: H.S. Fernando
Author: J.M. Theaker
Author: P.D. Simmonds
Author: M.C. Hayes
Author: G.M. Mead

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×